The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
Cosan S.A.
CSAN · the NYSE · USD · Market cap $2.7B
Cosan S.A.
FAIL · Does not pass the screenPrice as of 7 Nov 2026Daily close, not a live quoteLast reviewed 13 days ago
Screened 2026-11-07 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price2.75 USD at the 7 Nov 2026 close
- Fair valueUnder review: its inputs are 12 days old.
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed7 Nov 2026 (13 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-07).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Cosan S.A. holds its Markup at $2.75. The statistical read favours the buyers, held for 2 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 2 days |
| Price at the screen | $2.75 |
| Valuation | N/A trailing · 11.05 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.49 |
Five Screens: CSAN's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 331.00% | Below 33% | Fail |
| Interest-bearing cash | 130.42% | Below 33% | Fail |
| Receivables | 0.00% | Below 49% | Pass |
| Revenue purity | 8.00% | Below 5% | Fail |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Cosan's business is in a permissible area, but its interest-bearing debt is about 331% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CSAN's ethical verdict changes
Today CSAN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Its inputs are 12 days old. We show no fair value, margin of safety or value read built on it until the review clears.
Model construction and limits: fair-value methodology.
The Street's RangeThird-party analyst targets. The average target sits +11% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-07 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsBrazil fuel distributor trips on debt and losses
Every time a trucker fills up in Sao Paulo or ethanol moves from mill to port, the cash flows through Cosan. Yet this is not a business investors should chase. Weak moat, negative profit margins and an ethical screen failure on debt ratio mark it as one to pass.
Revenue growth of 26 percent looks lively, yet the firm posts a 24 percent profit margin and negative 30 percent return on equity. Forward earnings sit at 12.3 times, but this is a classic cyclical value trap in oil and gas refining. Peak-cycle numbers often flatter multiples that later collapse when commodity prices turn.
High leverage already tripped the ethical screen, and Brazil currency swings add further pressure. Four analysts see a higher target, yet the thin margin of safety offers little cushion against those swings. Analysis, not advice.
| Forward P/E | 11.0xexpensive even after accounting for its growth |
| EPS, trailing | -2.26 |
| EPS, forward | 0.25 |
| Revenue growth | +2.8%slow but positive growth |
| Profit margin | -22.2%currently unprofitable |
| Return on equity | -27.2%not currently earning a positive return on equity |
| FCF yield | -46.43% |
| Debt to equity | 1.91a meaningful debt load worth watching |
| Current ratio | 1.67healthy short-term liquidity |
| Beta | 0.49barely tracks the market's swings |
| Short interest, float | 0.00% |
| 52-week range | 2.38 - 5.61 |
| Moat | WEAK |
| Market cap | $2.7B |
CSAN-specific watchpoints · The things to watch: its business and earnings are exposed to Brazil and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 21.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 14.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (3 analysts) rates it hold, with a mean price target of $5.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Cosan SA (CSAN) (Q2 2026) Earnings Call Highlights: Strategic Deleveraging and Portfolio ... GuruFocus.com · 19 Aug 2026
- Cosan SA (CSAN) (Q2 2026) Earnings Call Highlights: Strategic Deleveraging and Portfolio ... Yahoo Finance · 19 Aug 2026
- Cosan S.A. Announces Material Fact Yahoo Finance · 18 Aug 2026
- Cosan Q2 Earnings Call Highlights MarketBeat · 17 Aug 2026
- Cosan Q2 Earnings Call Highlights Yahoo Finance · 17 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.00 | -33.9% | · | $661 | -33.9% |
| 2 months | $4.43 | -40.3% | · | $597 | -40.3% |
| 3 months | $4.30 | -38.5% | · | $615 | -38.5% |
| 6 months | $4.81 | -45.0% | · | $550 | -45.0% |
| 1 year | $5.95 | -55.6% | · | $445 | -55.6% |
| 2 years | $9.47 | -72.1% | $0.35 | $316 | -68.4% |
| 3 years | $13.96 | -81.1% | $0.35 | $214 | -78.6% |
| 5 years | $18.10 | -85.4% | $1.30 | $218 | -78.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CSAN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.